Search research articles
Contact Us
Filters
Showing results (111-120 of 138) with videos related to
Page
of 14
Sort By:
JHEP Reports : Innovation in Hepatology
|
October 27, 2025
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis
Lesley A Patmore, Lilian Y Liang, George Papatheodoridis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 14, 2020
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)
Milan J Sonneveld, Jun Yong Park, Apichat Kaewdech, et al.
JHEP Reports : Innovation in Hepatology
|
May 20, 2026
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: insights from a multicenter European cohort
Sabela Lens, Habiba Kamal, Arno Furquim d'Almeida, et al.
JHEP Reports : Innovation in Hepatology
|
July 24, 2023
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology
|
January 29, 2022
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Gastroenterology
|
September 28, 2023
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Gastroenterology
|
October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.
Journal of Viral Hepatitis
|
June 20, 2026
HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D
Dimitra Lakiotaki, Margarita Papatheodoridi, Vasilios Sevastianos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 8, 2023
HERACLIS-HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg-positive patients
George Papatheodoridis, Konstantinos Mimidis, Spilios Manolakopoulos, et al.
Contemporary Clinical Trials
|
October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Timothy Hardy, Kristy Wonders, Ramy Younes, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 138) with videos related to
Sort By:
Page
of 14
JHEP Reports : Innovation in Hepatology
|
October 27, 2025
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis
Lesley A Patmore, Lilian Y Liang, George Papatheodoridis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 14, 2020
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)
Milan J Sonneveld, Jun Yong Park, Apichat Kaewdech, et al.
JHEP Reports : Innovation in Hepatology
|
May 20, 2026
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: insights from a multicenter European cohort
Sabela Lens, Habiba Kamal, Arno Furquim d'Almeida, et al.
JHEP Reports : Innovation in Hepatology
|
July 24, 2023
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology
|
January 29, 2022
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Gastroenterology
|
September 28, 2023
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Gastroenterology
|
October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.
Journal of Viral Hepatitis
|
June 20, 2026
HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D
Dimitra Lakiotaki, Margarita Papatheodoridi, Vasilios Sevastianos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 8, 2023
HERACLIS-HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg-positive patients
George Papatheodoridis, Konstantinos Mimidis, Spilios Manolakopoulos, et al.
Contemporary Clinical Trials
|
October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Timothy Hardy, Kristy Wonders, Ramy Younes, et al.
Page
of 14